Europe
Novartis, a leader reimagining rheumatology and immunodermatology, announced positive new data from the PREVENT trial evaluating the efficacy and safety of Cosentyx® (secukinumab) in patients with nr-axSpA (non-radiographic axial spondyloarthritis).
Procarta Biosystems, a privately held UK-based biotech company, today announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines.
Surfcath eliminates need for Magill forceps during Less Invasive Surfactant Administration (LISA) method in preterm babies
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, has announced positive data from its ENCASE I* clinical trial.
CMR Surgical Limited announces that it has raised £195 million ($240 million) to fully fund the global commercialisation of the business.
Nordic Nanovector ASA (OSE: NANO) will host an R&D day in Oslo.
Santhera Pharmaceuticals will present data on the therapeutic effects of long-term treatment with Puldysa® in Duchenne muscular dystrophy at the forthcoming medical conferences of the European Paediatric Neurology Society, European Respiratory Society and World Muscle Society.
Khanu Management GmbH, a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG, based in Dortmund, Germany.
Crescendo Biologics Ltd announces that it has signed collaborations with world-renowned oncology research groups at the University of Oxford and the University of Surrey.
The two companies also inked a commercial licensing deal for Bayer to use One Drop’s platform in Bayer’s worldwide bio-digital efforts in oncology, cardiovascular disease and women’s health.
PRESS RELEASES